Literature DB >> 21763297

Combinatorial effect of TIMP-1 and α1AT gene polymorphisms on development of chronic obstructive pulmonary disease.

Manish Kumar1, D P Bhadoria2, Koushik Dutta3, Seema Singh4, Jyotsana Gupta5, Ram Kumar6, Anil K Chhillar7, Vibha Yadav8, Bharat Singh9, G L Sharma10.   

Abstract

OBJECTIVE: To study the role of α(1)AT and TIMP-1 gene polymorphisms in development of COPD. DESIGN AND METHODS: Blood samples from total 408 subjects (217 COPD patients and 191 controls) were used for genotyping and estimating biolevels of α(1)AT, TIMP-1 and inflammatory cytokines. Data was analyzed to determine the role of interaction of TIMP-1 and α(1)AT genes; and interplay between various genotypes and biolevels of α(1)AT, TIMP-1 and inflammatory cytokines in development of COPD.
RESULTS: Significantly low levels of α(1)AT and TIMP-1 were observed in COPD patients as compared to controls (P = 0.001), where as the inflammatory cytokines were found to be increased in patients. PIM3 allele of α(1)AT gene in COPD patients was found to be associated with low levels of α(1)AT (P = 0.001), the effect being more pronounced when PIM3 combined with rs6609533 of TIMP-1 gene (P = 0.0001). Combination of genotypes rs6609533 of TIMP-1 and PIM3 of α(1)AT containing the risk alleles was over-represented in patients (P = 0.005).
CONCLUSION: The SNP rs6609533 of TIMP-1 gene interacted with PIM3 of α(1)AT to make a possible risk combination for development of COPD.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763297     DOI: 10.1016/j.clinbiochem.2011.06.986

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Association of COL4A3 (rs55703767), MMP-9 (rs17576)and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to type 2 diabetes.

Authors:  Samira Saravani; Davood Yari; Ramin Saravani; Changiz Azadi Ahmadabadi
Journal:  Biomed Rep       Date:  2017-02-09

2.  Genomics of Chronic Obstructive Pulmonary Disease (COPD); Exploring the SNPs of Protease-Antiprotease Pathway.

Authors:  Manish Kumar; Neetu Phougat; Sonam Ruhil; Sandeep Dhankhar; Meenakshi Balhara; Anil Kumar Chhillar
Journal:  Curr Genomics       Date:  2013-05       Impact factor: 2.236

3.  Epigenome-wide association study of chronic obstructive pulmonary disease and lung function in Koreans.

Authors:  Mi Kyeong Lee; Yoonki Hong; Sun-Young Kim; Woo Jin Kim; Stephanie J London
Journal:  Epigenomics       Date:  2017-06-16       Impact factor: 4.778

4.  Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease.

Authors:  Yongan Wang; Na Li; Qiuyi Li; Zirui Liu; Yalan Li; Jingwei Kong; Ruijuan Dong; Dongyu Ge; Jie Li; Guiying Peng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-07

5.  The α(1)AT and TIMP-1 Gene Polymorphism in the Development of Asthma.

Authors:  Manish Kumar; D P Bhadoria; Koushik Dutta; Mitesh Kumar F; Bharat Singh; Seema Singh; Anil K Chhillar; D Behera; G L Sharma
Journal:  Comp Funct Genomics       Date:  2012-11-21

6.  The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis.

Authors:  Leonardo Lorente; Mar Martín; Fátima Plasencia; Jordi Solé-Violán; José Blanquer; Lorenzo Labarta; César Díaz; Juan María Borreguero-León; Alejandro Jiménez; José Antonio Páramo; Josune Orbe; José A Rodríguez; Eduardo Salido
Journal:  Crit Care       Date:  2013-05-25       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.